Allergy Drug Slows Tumor Growth in Animal Testing Studies

An anti-allergy drug, Cromolyn, has been found to slow pancreatic tumor growth in pre-clinical animal testing studies. It significantly and consistently increased the effectiveness of chemotherapy used to treat live mice with malignant pancreatic tumors. Pancreatic cancer is one of the deadliest forms of cancer and overcomes approximately 95% of people diagnosed. Scientists hope that Cromolyn may be able to increase the effectiveness of chemotherapy on humans who not only contract pancreatic cancer, but who contract many other types of cancer as well. If successful, these studies could not only directly improve the effectiveness of current cancer treatments and lengthen the lives of current cancer patients but forge a new path for future cancer research that could lead to even greater improvements.

http://www.medicalnewstoday.com/medicalnews.php?newsid=59498